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Abstract
Background. Data on the long-term survival and renal
function of patients with acute kidney injury (AKI) treated
with continuous renal replacement therapy are scarce.
Methods. We investigated the 3-year survival and need for
chronic dialysis in critically ill patients, who had survived
an episode of AKI requiring continuous renal replacement
therapy.
Results. A total of 206 ICU patients with AKI were random-
ized in a trial comparing haemofiltration versus haemodi-
afiltration. Of these, 95 (46%) survived at 90 days. Post-
discharge information relating to 3-year survival and renal
function was successfully obtained in 89 (94%) of the pa-
tients. Of the 89 patients studied, chronic kidney disease
(CKD) was present in 32 subjects from the onset, and CKD
developed de novo in 25 patients following AKI. End-stage
renal disease (ESRD) developed in 9 patients (of whom
8 had pre-existing CKD) and 29 patients died. Three-year
survival was 67% overall; the mortality at 3 years was 50%
for those with pre-existing kidney disease, and 71 and 82%
for those with de novo and without CKD, respectively.
Conclusion. After an episode of AKI necessitating a con-
tinuous renal replacement therapy, rapid progression to
ESKD is commonly observed in patients with pre-existing
chronic renal impairment. Medical care with an emphasis
on nephroprotection is necessary in these patients.
Keywords: acute kidney injury; continuous renal replacement therapy;
long-term survival
Introduction
Acute kidney injury (AKI) affects as many as 30% of pa-
tients admitted in intensive care units (ICU) [1]. The aeti-
ology in 90% of ICU-related AKI is acute tubular necrosis
(ATN), occurring most commonly in the context of
multiple-organ failure. Due to recent improvements in in-
tensive care techniques, the in-hospital mortality rate of
patients with AKI requiring dialysis has declined over the
past 20 years from 41 to 28% [2]. However, many pa-
tients who have an episode of ICU-related AKI nowadays
are elderly and have severe co-morbidities and in this con-
text, the incidence of AKI has been increasing over the
past decades [2–4]. Data on their long-term survival are
scarce and often conflicting. Before 1980, <10% of patients
with ATN ended in end-stage renal failure [5]. At 1-year
follow-up, only 1% of the patients surviving an episode
of ICU-related AKI requiring renal replacement therapy
(RRT) were found to have an ongoing requirement for RRT
[6]. No prognostic factor for end-stage renal failure could be
identified in this study. Longer follow-up of this cohort was
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recently published and at 5 years, 5% of the patients still
alive needed maintenance dialysis [7]. The longest follow-
up (10 years) of 187 patients with AKI showed that 71%
of those with chronic renal dysfunction prior to the episode
of AKI (n = 100) died within the follow-up but only 2 pa-
tients needed dialysis in this cohort [8]. Other authors are
less optimistic, reporting a chronic dialysis rate up to 20%
in survivors of ATN [9]. In this study, we investigated the
3-year survival and need for chronic dialysis in critically ill
patients who had both taken part in a randomized controlled
trial comparing different doses of RRT, and were still alive
90 days after their episode of AKI [10].
Patients and methods
Between October 2000 and December 2003, 206 ICU patients with AKI
were included in a controlled randomized trial comparing haemofiltration
and haemodiafiltration [10]. Details of this study were already published.
Data on 3-year survival and level of renal function prior to and after AKI
were obtained in those who survived >90 days by referring to the Geneva
population registry or their medical records (hospital or private physician).
Normal renal function prior to the episode of AKI was determined by
an estimated GFR (eGFR) ≥60 ml/min according to the MDRD study
equation [11]. Only serum creatinine values measured 1 month prior to
AKI were considered as valid when calculating the eGFR to determine the
renal function prior to AKI. Patients without premorbid creatinine but who
had at discharge an eGFR ≥60 ml/min were considered to have no CKD
prior to AKI. Non-return to baseline values was diagnosed as incomplete
recovery. An eGFR ≤ 60 ml/min prior to AKI was defined as prior CKD
and at hospital discharge or at 90 days post-AKI as de novo CKD. End-
stage kidney disease (ESKD) was defined as CKD requiring maintenance
dialysis.
Statistical analysis
The chi-square and t-tests were used to compare demographic and baseline
characteristics of 3-year survivors and non-survivors. Significant P-values
were <0.05.
A Kaplan–Meyer analysis was used to determine 3-year
survival among patients without CKD and those with known or de novo
CKD.
Results
Of the 206 patients who took part in the randomized trial,
95 were still alive at 90 days after implementation of RRT.
Three-year data on survival and level of renal function were
obtained in 89 (94%) patients. Six patients were transferred
to other countries and were lost to follow-up. Premorbid cre-
atinine values were obtained in 71 patients. Baseline demo-
graphic and clinical characteristics of 3-year survivors and
non-survivors are listed in Table 1. At discharge, complete
recovery (within ± 10% baseline eGFR or discharge eGFR
>60 ml/min) was present in 32 out of 89 patients, dialysis
dependence was present in 4 patients and the remainder
had partial recovery. The 32 patients with full recovery at
discharge had a steady renal function during follow-up.
Patients with de novo CKD after AKI
During the 3-year follow-up, of the 25 patients who devel-
oped CKD after AKI, 1 became dependent on dialysis, 5
improved their eGFR, 13 decreased their eGFR and 6 had
a steady eGFR.
Table 1. Clinical and laboratory characteristics of patients at 3-year
survival (except for serum creatinine)
Survivors
(n = 60)
Non-survivors
(n = 29)
Age (year) 58 ± 16 68 ± 11†
Male gender (%) 50 66
Diabetes (%) 18 21
Diagnosis of AKI (trauma/
surgical/medical)
6/9/45 1/12/16†
Apache II score 23 ± 8 18 ± 6††
Sepsis (%) 60 41.4
RRT duration (day) 3 (2–5) 4 (2–5)
Serum creatinine prior to AKI
Mean, median, (range)
(µmol/l)
118, 98 (40–302) 141,119 (54–350)
eGFR prior to AKI
(ml/min)
52 (14) 47 (14)
CKD prior to ARF (%) 27 55††
Serum creatinine at discharge or 90 days
Mean, median, (range)
(µmol/l)
144, 100 (52–1060) 161, 135 (39–378)
eGFR at discharge or 90
days (ml/min)
46 (17) 40 (20)
CKD at discharge or 90
days (%)
55 79
Last serum creatinine prior to death or at 3 years
Mean, median, (range)
(µmol/l)
121, 88 (54–535) 196, 154 (53–546)††
eGFR prior to death or at 3
years (ml/min)
47 (17) 30 (19)
CKD prior to death or at 3
years (%)
57 79†
Data are given as mean ± SD or median and IQR.
†P < 0.05, ††P < 0.01.
BUN: blood urea nitrogen.
Patients with CKD prior to AKI
Among the 32 patients with CKD prior to AKI, 4 had an
increase in eGFR, 10 had a decrease, 8 ended in ESKD
and the remainder had a stable renal function during the
follow-up.
At discharge, eight patients were classified with stage V
(NKF/DOQI classification), of whom one improved during
follow-up (stage IV CKD). Fifteen were classified with
stage IV CKD of whom 2 improved during follow-up (stage
III CKD), 8 remained stage IV and 5 ended in stage V.
Among the 26 classified at discharge with stage III CKD,
1 improved his renal function during follow-up (stage II
CKD), 9 worsened their renal function (2 stage V CKD
and 7 stage IV) and 16 remained stage III. Among the 40
classified at discharge with ≤stage II CKD, 28 remained
stable and 12 worsened their renal function during follow-
up (2 stage V CKD, 1 stage IV, 9 stage III).
Survival
Overall survival in patients with AKI requiring continuous
RRT (CRRT) dropped from 46% (n = 95/206) at 90 days
to 30% (n = 60/201) at 3 years.
Overall 3-year survival in the 89 survivors at 90 days was
67%. Among those who died within these 3 years, 79% had
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Fig. 1. Kaplan–Meyer analysis of 3-year survival rates in patients without
(no CKD prior to AKI) and with prior (prior CKD to AKI) or de novo
CKD after AKI.
CKD either prior to AKI (55%) or de novo developing
after AKI (24%), whereas only 55% of survivors had CKD
(27% prior to AKI and 28% de novo developing after AKI).
Three-year survival was 50, 71 and 82% in 90-day survivors
with prior, de novo and without CKD (log-rank test = 8.32,
P = 0.016), respectively (Figure 1).
Discussion
In our study of critically ill patients with AKI, those who
survived 90 days had a yearly mortality of almost 6%/year
during the following 3 years. This rate is more than 10-fold
higher than the annual mortality observed in the general
population of Geneva residents aged 61–70 (0.8% mortality
for the years 2004–2006; Office Cantonal de la Statistique,
Geneva). Overall 3-year mortality in the 206 patients orig-
inally enrolled in our trial was 70%. These results are
in accordance with those previously published. A recent
prospective cohort study with 425 patients treated for ATN
with RRT mentioned 53 and 35% survival at discharge and
at 1-year follow-up, respectively [6]. In the studies with a
long follow-up period, 5-year mortality in Finnish patients
requiring RRT was reported to be between 50 and 70%
[12,13]. A retrospective survey of 301 German ICU pa-
tients with severe AKI found a 5-year survival of only 50%
amongst discharged patients [14].
Mortality increased in our patients with CKD, with the
highest rate observed in those with known CKD prior to
AKI, and our results confirm CKD as an important risk
factor for death in the general population [15].
It is often accepted that the outcome of AKI is binary:
death or survival without the need of RRT, principally be-
cause AKI is commonly held to recover in the vast majority
of survivors. In a recently published analysis of an inter-
national cohort encompassing 1218 patients treated with
CRRT, 14% were still dialysis dependent at hospital dis-
charge [16]. Patients who are, however, dialysis free at 90
days post-AKI generally remain so at 1 year, as suggested
by the recently reported 1 and 5% incidences of ESKD at 1
and 5 years in patients with ATN requiring RRT [5,7]. In this
prospective study, nearly half of the survivors were, how-
ever, discharged with moderate-to-severe CKD and none
of these patients were known to have CKD prior to the
onset of AKI. More discouraging results have, however,
also been reported, with prevalence of ESKD ranging from
10 to 16.2% in studies with a long follow-up [9,14,17]. A
large retrospective cohort study of 2202 patients treated by
RRT (86% by CRRT and 15% by intermittent haemodial-
ysis), of whom 1102 survived 90 days post-AKI, showed
a long-term 11.9% incidence of ESKD [14]. Information
on post-discharge renal function of 301 German ICU long-
term survivors was obtained in 130 patients [14]. CKD was
present in 41% of the patients and 10% required mainte-
nance dialysis. The results of our study support these data
as the 3-year incidence of ESKD among our survivors was
10%. Notably, our patients with previous CKD had a 25%
incidence of ESKD at 3 years. In addition, the prevalence
of CKD was elevated with nearly one in two patients with
no known CKD prior to AKI progressing to CKD within
3 years.
Our study has some limitations. Though prospective, this
observational study relies on a limited sample of patients
and lacks statistical power to determine which factors are
predictive of long-term survival and the need of RRT.
Our population also had a high prevalence of patients
with previous CKD and results may not be extrapolated to
other world populations, particularly outside the western
hemisphere.
Data were not collected on other co-morbidities such as
neoplasia or cardiovascular disorders, nor was the presence
or absence of a nephrological follow-up recorded.
Despite its shortcomings, this observational study con-
firms that after an episode of AKI necessitating CRRT,
rapid progression to ESKD is only exceptionally observed
in patients with normal renal function prior to the acute
renal injury, although one in two patients will progress to
CKD. These results will, however, need to be confirmed by
a larger prospective study analysing long-term outcomes in
these patients. We, however, recommend that patients who
develop CKD after AKI should be considered at risk of
progressing to ESKD. In this regard, they should receive
medical care with an emphasis on nephroprotection, for
example detection and treatment of hypertension, coronary
heart disease, calcium and phosphate metabolism distur-
bances and anaemia. Also of note, patients with pre-existing
CKD prior to the episode of AKI are at high risk of pro-
gressing rapidly to ESKD following an episode of AKI;
25% of our patients with previous CKD developed end-
stage renal disease within 3 years after AKI. Pre-dialysis
care with preparation for RRT is therefore recommended
for these patients.
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